Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.
Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, Ganser A, Nagler A, Snowden JA, Robin M, Passweg J, Van Gorkom G, Wallet HL, Hoek J, Blok HJ, De Witte T, Kroeger N, Hayden P, Chalandon Y, Agha IY. Masouridi-Levrat S, et al. Bone Marrow Transplant. 2022 Jan;57(1):23-30. doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 1. Bone Marrow Transplant. 2022. PMID: 34599284 Free PMC article.
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.
Beauverd Y, Roosnek E, Tirefort Y, Nagy-Hulliger M, Bernimoulin M, Tsopra O, Ansari M, Dantin C, Casini A, Grandjean AP, Chigrinova E, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Biol Blood Marrow Transplant. 2014 Sep;20(9):1322-8. doi: 10.1016/j.bbmt.2014.04.023. Epub 2014 Apr 24. Biol Blood Marrow Transplant. 2014. PMID: 24769318 Free article.
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR, Schanz U, Chalandon Y, Güngör T, Baldomero H, Heim D, Nair G, Medinger M, Masouridi-Levrat S, de Faveri GN, Tiercy JM; Swiss Blood Stem Cell Transplantation Group. Passweg JR, et al. Bone Marrow Transplant. 2015 Sep;50(9):1201-5. doi: 10.1038/bmt.2015.129. Epub 2015 Jun 8. Bone Marrow Transplant. 2015. PMID: 26052916
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants.
Masouridi-Levrat S, Simonetta F, Beauverd Y, Tsopra O, Tirefort Y, Stephan C, Levrat E, Ansari M, Verholen F, Roosnek E, Passweg JR, Chalandon Y. Masouridi-Levrat S, et al. Bone Marrow Transplant. 2016 Jun;51(6):860-2. doi: 10.1038/bmt.2015.356. Epub 2016 Feb 8. Bone Marrow Transplant. 2016. PMID: 26855156 No abstract available.
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.
Beauverd Y, Roosnek E, Tirefort Y, Dantin C, Ansari M, Tsopra O, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Bone Marrow Transplant. 2016 Jul;51(7):955-60. doi: 10.1038/bmt.2016.34. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950373 Free article.
75 results